Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) will likely be releasing its results before the market opens on Thursday, August 20th. Analysts expect Novozymes A/S to announce earnings of $0.60 per share and revenue of $1.2708 billion for the quarter.
Novozymes A/S Stock Down 0.4%
Shares of OTCMKTS:NVZMY opened at $64.19 on Wednesday. The firm has a fifty day moving average price of $63.30 and a two-hundred day moving average price of $60.47. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.67 and a quick ratio of 1.03. Novozymes A/S has a one year low of $49.90 and a one year high of $66.66. The company has a market cap of $26.61 billion, a price-to-earnings ratio of 43.37, a PEG ratio of 3.07 and a beta of 0.92.
Analyst Upgrades and Downgrades
NVZMY has been the topic of several research analyst reports. Kepler Capital Markets raised shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Zacks Research raised Novozymes A/S from a “strong sell” rating to a “hold” rating in a research note on Monday, June 8th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy”.
Novozymes A/S Company Profile
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
Read More
- Five stocks we like better than Novozymes A/S
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
